| Trial ID: | L5516 |
| Source ID: | NCT00324675
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00324675/results
|
| Conditions: |
Type 2 Diabetes|Overt Diabetic Nephropathy
|
| Interventions: |
DRUG: Rosiglitazone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Proteinuria, at baseline and after 6 and 12 mo of treatment | Secondary: Renal Hemodynamic, at baseline and after 6 and 12 mo of tretament|Renal Function, at abseline and after 6 and 12 mo|Adverse Event, every month or at occurence|HbA1c, at baseline and after 6 and 12 mo
|
| Sponsor/Collaborators: |
Sponsor: Technische Universität Dresden
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
28
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2010-12
|
| Results First Posted: |
2011-10-21
|
| Last Update Posted: |
2011-11-02
|
| Locations: |
University hospital Dresden, Dresden, 01307, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00324675
|
